Trial intelligence / Profile preview

Pulse methylprednisolone for ocular involvement in Behcet's disease

IRCT201011235235N1Phase 4Completed

Sponsor
Rheumatology Research Center
Start
May 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of methylprednisolone in Behçet's disease (BD), sponsored by Rheumatology Research Center. Started May 2010; status: completed.

02

Drugs

methylprednisolone
03

Conditions

Behçet's disease (BD)

Beyond the preview

Go deeper on IRCT201011235235N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201011235235N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call